Oriola-KD Corporation completes its Russian acquisition
Oriola-KD acquired 75 per cent of the Russian companies in April 2008. The acquisition price for the remaining 25 per cent is EUR 65.0 million (USD 95.0 million). The total purchase price paid for the Russian companies is EUR 153.7 million (USD 226.0 million) in cash. In addition Oriola-KD has provided the Russian companies with long-term financing amounting to approximately EUR 65 million (USD 95 million).
In 2009 the net sales of Russian pharmaceutical retail and wholesale operations were EUR 480.7 million (2008 pro forma EUR 414.9 million) and operating profit was EUR 44.5 million (2008 pro forma EUR 7.4 million). The Russian companies had 3023 (3482) employees at the end of 2009.
"Our partnership during the last two years with the founders of the Russian companies has contributed very positively to the success of the businesses. Sizeable investments and joint efforts to improve operations have enabled the growth and the increased efficiency", said Eero Hautaniemi, President and CEO, Oriola-KD Corporation.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.